Belval Camille Challan, Barranger Emmanuel, Dubernard Gil, Touboul Emmanuel, Houry Sidney, Daraï Emile
Service de Gynécologie-Obstétrique, Hôpital Tenon, Faculté Saint-Antoine, Assistance Publique des Hôpitaux de Paris, CancerEst, Université Pierre et Marie Curie-Paris6, 4 rue de la Chine, 75020 Paris, France.
Gynecol Oncol. 2006 Sep;102(3):580-2. doi: 10.1016/j.ygyno.2006.02.033. Epub 2006 Apr 19.
The risk of wound metastasis after laparoscopic management of early-stage cervical cancer is well known, but there are few data on peritoneal carcinomatosis of cervical adenocarcinoma.
We report the first case of peritoneal carcinomatosis occurring in a woman with FIGO stage Ib1 cervical adenocarcinoma who underwent laparoscopic type III radical hysterectomy and bilateral pelvic lymphadenectomy (sentinel node procedure) followed by vaginal brachytherapy. A peritoneal recurrence was diagnosed 16 months after surgery and was treated with chemotherapy and laparotomy.
Laparoscopy for cervical adenocarcinoma may carry a risk of peritoneal dissemination.
早期宫颈癌腹腔镜治疗后伤口转移的风险是众所周知的，但关于宫颈腺癌腹膜种植转移的数据却很少。
我们报告了首例腹膜种植转移发生在一名国际妇产科联盟（FIGO）Ib1期宫颈腺癌女性患者身上，该患者接受了腹腔镜III型根治性子宫切除术和双侧盆腔淋巴结清扫术（前哨淋巴结手术），随后进行了阴道近距离放疗。术后16个月诊断为腹膜复发，并接受了化疗和剖腹手术。
腹腔镜治疗宫颈腺癌可能存在腹膜播散的风险。
